We are live on ! Find out more
AA

Altrafin AG Portfolio holdings

AUM $255M
1-Year Est. Return 21.67%
This Fund
S&P 500
This Quarter Est. Return
-3.52%
1 Year Est. Return
+21.67%
3 Year Est. Return
+97.62%
5 Year Est. Return
10 Year Est. Return
AUM
$229M
AUM Growth
+$6.63M
Cap. Flow
+$16.9M
Cap. Flow %
7.38%
Top 10 Hldgs %
44.41%
Holding
75
New
4
Increased
22
Reduced
29
Closed
8

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$4.98M
2
GLD icon
SPDR Gold Trust
GLD
+$3.75M
3
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$3.74M
4
CVS icon
CVS Health
CVS
+$2.52M
5
NEM icon
Newmont
NEM
+$2.03M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.87M
2
MMM icon
3M
MMM
+$1.69M
3
ADBE icon
Adobe
ADBE
+$771K
4
UNH icon
UnitedHealth
UNH
+$576K
5
TDOC icon
Teladoc Health
TDOC
+$532K

Sector Composition

Rank Sector Weight
1 Technology 28.94%
2 Financials 20.71%
3 Communication Services 11.71%
4 Healthcare 8.99%
5 Materials 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$19.1M 8.31%
60,404
-1,549
-3% -$512K
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.12T
$16.3M 7.09%
124,285
-2,158
-2% -$279K
ACWI icon
3
iShares MSCI ACWI ETF
ACWI
$32B
$14.9M 6.48%
161,000
+39,000
+32% +$3.74M
JPM icon
4
JPMorgan Chase
JPM
$916B
$10.8M 4.71%
74,449
+5,543
+8% +$831K
AMZN icon
5
Amazon
AMZN
$2.44T
$7.98M 3.48%
62,752
-1,777
-3% -$238K
NVDA icon
6
NVIDIA
NVDA
$4.6T
$7.41M 3.23%
170,380
-41,780
-20% -$1.87M
CVS icon
7
CVS Health
CVS
$135B
$6.82M 2.97%
97,650
+35,525
+57% +$2.52M
AAPL icon
8
Apple
AAPL
$4.97T
$6.74M 2.94%
39,353
-1,714
-4% -$314K
MA icon
9
Mastercard
MA
$498B
$6.05M 2.64%
15,276
+2,916
+24% +$1.17M
BAC icon
10
Bank of America
BAC
$429B
$5.89M 2.57%
215,200
+64,870
+43% +$1.92M
ICE icon
11
Intercontinental Exchange
ICE
$87.2B
$5.83M 2.54%
53,020
-3,950
-7% -$453K
TSM icon
12
TSMC
TSM
$1.94T
$5.76M 2.51%
66,235
+630
+1% +$59.6K
ADBE icon
13
Adobe
ADBE
$105B
$5.72M 2.49%
11,226
-1,470
-12% -$771K
FTNT icon
14
Fortinet
FTNT
$112B
$5.58M 2.43%
95,070
+4,110
+5% +$272K
META icon
15
Meta Platforms (Facebook)
META
$1.49T
$5.43M 2.36%
18,072
-681
-4% -$205K
CRWD icon
16
CrowdStrike
CRWD
$183B
$5.4M 2.35%
128,956
-4,848
-4% -$188K
NVO
17
Novo Nordisk
NVO
$228B
$5.34M 2.33%
58,772
+3,350
+6% +$295K
FNV icon
18
Franco-Nevada
FNV
$41.3B
$5.14M 2.24%
38,500
+6,605
+21% +$934K
PYPL icon
19
PayPal
PYPL
$50.3B
$4.76M 2.08%
81,505
-7,860
-9% -$512K
SPGI icon
20
S&P Global
SPGI
$124B
$4.63M 2.02%
+12,676
New +$4.98M
NEM icon
21
Newmont
NEM
$96.2B
$4.55M 1.98%
123,045
+49,975
+68% +$2.03M
HON icon
22
Honeywell
HON
$76.4B
$4.16M 1.81%
23,915
-180
-0.7% -$32.9K
DIS icon
23
Walt Disney
DIS
$171B
$4.03M 1.75%
49,669
+2,480
+5% +$212K
WFC icon
24
Wells Fargo
WFC
$254B
$3.64M 1.59%
89,180
-220
-0.2% -$9.5K
GLD icon
25
SPDR Gold Trust
GLD
$131B
$3.6M 1.57%
+21,000
New +$3.75M

Similar funds

Altrafin AG's Q3 2023 Portfolio in Review

As of Q3 2023, Altrafin AG held 75 positions worth $229M, up 3% from $223M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Altrafin AG deployed $16.9M of net new capital in Q3 2023, opening 4 new positions and adding to 22 existing holdings. Its largest new stake was S&P Global: 12,676 shares worth $4.63M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 33% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was NVIDIA, an estimated $1.87M trimmed.

  • Altrafin AG's largest Q3 2023 buy was S&P Global: 12,676 shares worth $4.63M.
  • Altrafin AG added most to iShares MSCI ACWI ETF in Q3 2023, an estimated $3.74M increase.
  • Altrafin AG's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.87M.
  • Altrafin AG fully exited 3M in Q3 2023, selling an estimated $1.69M.
  • Altrafin AG's ten largest holdings make up 44% of its $229M portfolio in Q3 2023.
  • Altrafin AG opened 4 new positions and closed 8 in Q3 2023.
  • Altrafin AG's portfolio value rose 3% quarter-over-quarter to $229M.

Based on Altrafin AG's 13F filing for Q3 2023, filed 17 Feb 2026.